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Polymers in Contact with the Body
by Robert N. King* and Donald J. Lyman*
The clinical use of polymeric materials in the body to repair and restore damaged or
diseased tissues and organs is substantially increasing on an annual basis. Concomitant
with this use is an increase in materials related research on medically used polymers.
Information on the historical and current clinical use of polymeric materials is provided
in order to establish a basis for the philosophy and problems encountered in assessing
the acceptability of various polymers in the biological system. The requisite properties
which must be demonstrated by a polymer in contact with the body are discussed from
two viewpoints, i.e., the effects of the material on the stability of the host and the effects
of the host on the stability of the material. In addition, the effects of synthesis,
processing, storage, sterilization, implantation, and possible degradation of polymers
are discussed, poly(ethylene terephthalate) being used as an example.
The use of materials in the body to repair
or restore damaged, diseased, or ravaged tissue
and organs is not new (1). First recorded
use was from the Edwin Smith Surgical
Papyrus, nearly 4000 years old, describing the
use of stitches (sutures) in wound repair. Ex-
tensive use of a variety of suture materials
such as braided horsehair, leather strips, cotton
fibers, animal sinews, and bark from the
Ashmantaka tree was recorded in ancient
Indian literature nearly 2500 years ago.
The first recorded use of nonbiological ma-
terials came in 1550, with the use of gold wires
as sutures. This was followed shortly by the
first use of a biomedical device, a gold plate
to repair a cleft palate. Later in the 1800's
there were numerous reports of metal plates
and pins to fix broken bones. During the last
several decades, advancements in the field of
materials and surgery has enabled the surgeon
to literally rebuild many parts of the human
body with artificial parts, organs, and other
supporting structures. The large increase in
the variety of implants was concurrent with
the expansion of the polymer industry and the
availability of polymeric materials having
* Department of Materials Science and Engineering,
Department of Surgery and Division of Artificial
Organs, University of Utah, Salt Lake City, Utah
84112.
properties more similar to the body than their
metal counterparts.
The recent use of polymers in surgery have
been quite broad: temporary assist materials,
such as sutures, surgical adhesives, plasma
extenders, relatively simple artificial parts of
a more permanent nature, such as vascular
grafts, heart valves, hydrocephalic drain tubes,
joints, tendons, reinforcing meshes, as well
as a variety of softtissue replacement materials
for cosmetic surgery; and the more complex
devices such as the artificial kidney, the
artificial lung, the artificial heart, etc., which
can simulate some physiological process. Indeed,
the imagination and skill of the surgeon, and
more recently the support and technical assist-
ance of scientists and engineers, have resulted
in a great variety of devices and parts being
commercially available (2).
However, this progress has not been without
failure. Most failures have been due to improper
choice or processing of the material for the
intended use. For example, silicone rubber
heart valve poppets can absorb fatlike sub-
stances from the blood stream, causing mal-
function, fracture of the ball valve, and
ultimately, death of the patient (8). Also, a
number of total hip prostheses whose acetabular
cups were made of Teflon required reoperation
and removal of the implant because continued
compressive stresses caused the polymer to
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end result was failure of the device after one
or two years (4).
In many instances, the proper material for a
given application has yet to be developed. Those
polymers most often used are those readily
available from many commercial processes, and
practically all are intended for uses and environ-
ments which vastly differ from that found in
the body. By proper engineering of the implant,
however, a successful part for limited use may
be obtained. Vascular grafts represent a good
example of this.
Early work on synthetic polymer vascular
grafts involved solidwall tubes (5). However,
thrombus and/or damage to the soft vessel
walls at the junction with the rigid tube, lead
to minimal success (6). More extensive studies
in adapting these synthetic polymers to vessel
wall replacement focused on the findings that
porosity appeared to be a necessary require-
ment (7,8) and was most easily achieved by
the use of polymer fibers processed in fabrics
or knitted into tubings.
A number of commercial fibers were explored.
Of these, poly(ethylene terephthalate), or
Dacron, appeared to be the better material in
terms of its minimal toxicological response, its
durability, and its mechanical properties. There
were problems, however, such as seepage of
blood because of the porosity; occlusion of the
vessel in smaller diameter grafts, or in grafts
in the venous system; and a process of fibrous
ingrowth, contraction, calcification, etc., which
occasionally caused failure. The latter appears
to be the result of a normal wound healing re-
sponse within the graft structures. Neverthe-
less, an acceptable arterial prosthesis was now
available to the surgeon (from a nonblood-
compatible polymer) even though there were
limits to its use in terms of graft internal
diameter, and location in the vascular system.
Concurrent with these studies have been
the improvements in development of artificial
lung devices, artificial kidneys, and arterio-
venus shunts which allow repetitive extra-
corporeal dialysis, heart valves, and more re-
cently the artificial heart and various heart
assist devices. As a result of these developments,
there is an increased emphasis on biomedical
materials. A recent paper (9) describes 17 new
potentially blood-compatible surfaces, none of
which were available prior to 1960. However,
of these only the polyurethane types have
reached some degree of availability in devices.
Of the many problems associated with bio-
medical polymer research, the need for a better
understanding of the environment in which a
polymer is used is perhaps most important.
Even with this knowledge an improper device
design or an improper implantation technique
can often mask a good material. Thus the search
for new biomedical polymers must truly be an
interdisciplinary activity.
Many of the problems reported for polymeric
implants could conceivably be eliminated if
"pure" high molecular weight polymers were
used. The large amounts and infinite variety
of additives in polymers are perhaps the most
significant contributors to the biological re-
sponse evoked after their implantation. For
example, a variety of additives, such as plastic-
izers, antioxidants, ultraviolet and radiation
stabilizers, antiozonants, residual monomers,
and catalysts, and in the case of textiles, sizing
and finishing agents, whiteners, antistatic
agents, and even flame retardants are occasion-
ally released by the polymer at the site of
implantation. While some investigators have
attempted to make these polymers more medi-
cally acceptable for their studies by an ex-
tensive series of washings and extractions in
an attempt to eliminate the additives, these
processes are only successful to a point. The
mechanical properties of the polymer are often
affected by the extraction process. Thus, a com-
promise must be reached between the relative
impurity levels in the material and the retention
of adequate mechanical behavior. Also, the re-
maining concentrations of impurities can still
effect the overall biotolerability of the im-
planted polymer.
These additives are not needed in implant
polymers. However, because of the low pound-
age of polymer needed in these applications,
many device makers have been forced by
economics to use nonmedical grade materials.
This lack of a large commercial market for
biomedical polymers has deterred large com-
mercial companies from entering the field. In
addition, the general shortage of materials
scientists who have interacted with medical
research has also been a major factor in the
slow development and use of new polymeric
materials designed specifically for biomedical
applications.
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able awareness of the inherent problems asso-
ciated with polymeric implants has developed,
and a more unified approach to the problem
of the use of a synthetic material as an implant
has evolved. This considered the implanted
material from two standpoints: the effect of the
particular implant upon the body, from the
cellular to the systemic level, and the effect of
the body on the implant. The latter is important
in determining the long-term performance
of the implant in the body environment.
Complete answers to these effects are not
available this time. The considerable amount
of empirical information currently available
on the use and performance of a variety of
materials in the body and related physiological
environments does, however, make it possible
to outline the characteristics that must be con-
sidered when investigating polymers for bio-
medical applications (1).
In determining the effect of the implant on
the body, the characteristics of the material
that must be considered are: toxic or irrita-
tional qualities of the material or its break-
down products (molecular level), or of additives
incorporated into the material; mechanical
characteristics of the material; fabricability of
the material into the desired implant form and
the effect offabrication on alteringthe material,
i.e., oxidation of the surface, residual solvent,
mold contamination, etc.; quantity of the ma-
terial (systemic level); size and shape of the
material (tissue level); surface structure of
the material (cellular level); sterilizability of
the material; possible antigenicity of the ma-
terial (immunological response); thrombogeni-
city; antileukotaxis (infection predisposition);
carcinogenesis.
In determining the effect of the body on the
implant, the material must be examined for
changes such as: degradation or other changes
in molecular structure (i.e. crosslinking or
phases); changes in mechanical properties;
wear particles; state of hydration; elution of
low molecular weight species; protein satura-
tion or oxidation of the surface; cellular in-
growth; calcification.
As one can see, an implant polymer is ex-
posed to a variety of microenvironments within
the body; the degree of response which is
acceptable depends on how long the implant
must remain functional. One area of response
that is influenced by many of the synthesis
and processing variables discussed in the earlier
papers of this symposium is the degradation of
the polymer in the physiological environment.
Thedegradation ofpoly(ethyleneterephthalate)
or PET, can be used as an example.
Because of its extensive use as a textile
fiber, much is known regarding the nonphysio-
logic degradation mechanisms of PET. These
include thermal (10), oxidative (11), radiation-
induced (12), and hydrolytic (13) degradations.
Application of these mechanisms to the analysis
of PET as an implant material produces inter-
esting implications, especially when consider-
ing the environment to which an implant is
subjected, i.e., storage, sterilization (and in
some cases repeated sterilization), and im-
plantation.
The storage environment, for example, of
an implant is obviously a point worthy of con-
sideration. However, far too many variables
are present, such as environmental conditions
of the storage area, materials stored with the
implant, lighting facilities, and even initial
packaging procedures, to lend any concrete
evidence to degradation resulting from storage.
Interesting enough, however, are the facts that
information or instructions are almost never
listed on packaged implants regarding their
storage, and that most are supplied as "sterile"
packages with no indication of prior steriliza-
tion procedures.
Sterilization effects on polymeric materials
are very seldom given proper attention. Most
polymers are not sufficiently thermally stable
to withstand a dry heat sterilization technique
(160-180°C). In the case of PET textile
materials, ethylene oxide sterilization requires
long waiting periods (several days in some
cases) before the residual traces of the gas are
removed from the implant after its exposure.
y-radiation sterilization (often used in sterile
packaging) could lead to severe degradation
reactions, depending on the dosage and time
of exposure. Thus, the method of choice is
usually steam sterilization at temperatures
ranging from 1200C to 1350C (14) for time
periods which average 15 to 20 min. In some
cases, such as flash autoclaving, even higher
temperatures are used for shorter periods of
time.
Thus, it is conceivable that even before the
PET has been implanted, it may have been
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dictions of its function life are not possible. Not
all of this results from hydrolysis of the labile
ester linkages in PET, but also involves
abnormal linkages present in the chain due
to the thermal nature of the PET polymer
synthesis. As a result of these linkage varia-
tions, Buxbaum (11) has proposed that oxida-
tive degradation can occur in PET at a tempera-
ture as low as 100°C. The mechanism he pro-
poses is based on the attack of abnormal
diethylene glycol segments within the chain
reported to be present in concentrations of
2.0-2.5 mole-% (15). Miyagi (13) has shown
that extensive hydrolytic attack of PET with
water can take place at 130°C in 24 hr, mainly
concentrated in the amorphous regions of the
polymer. Asmus and Fleissner (16) report that
ester bonds in PET are prone to hydrolysis and
recommend that the permanent use of the ma-
terial in steam or water above 70°C should be
avoided. Furthermore, Scales and Lowe (17)
have reported that autoclaved PET disinte-
grated after refluxing in a normal saline
solution. As a further extension of degradation
mechanisms, virtually nothing is known regard-
ing the susceptibility of PET to attack under
physiologic conditions by enzymes, proteins,
etc.
Thus, much more research must be done in
the area of both short-term and long-term
degradation effects of polymer implant ma-
terials in order to establish viable performance
standards. While this has not been a serious
problem with implants thus far, it remains to
be seen whether its significance is justified.
In summary, what we hope to have accom-
plished in this brief review of polymers in
contact with the body is a demonstration of the
complexity of the interaction of the body and
the polymer implant. While careful, meaningful
research in the bioengineering field is difficult
and extremely time-consuming, it must be ac-
complished if serious health hazards are to be
kept to a minimum in the future.
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